Research Roundup

Debbie Rigby rounds up the latest in research news Harms and benefits of sodium‑glucose co‑transporter 2 inhibitors Sodium-glucose co-transporter 2 inhibitors are oral glucose-lowering drugs that increase the urinary excretion of glucose. In patients with type 2 diabetes and cardiovascular disease they reduce all-cause mortality, cardiac mortality, rates of hospitalisation for heart failure and the